How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?

  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?

  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?

  • Question on Document

    We would like to draw your attention to the new minimum evidence standards section (section 5). Please consider it and comment on whether it reflects sufficient criteria for future NICE recommendations of digital technologies for supporting self-management of COPD.

  • Question on Document

    Are there any implementation considerations for digital technologies for supporting self-management of COPD that we may have missed?
The content on this page is not current guidance and is only for the purposes of the consultation process.

Evidence generation plan

Closed for comments This consultation ended on at   Request commenting lead permission

6 Implementation considerations

The following considerations around implementing the evidence generation process have been identified through working with system partners:

  • The digital technologies for supporting self-management of COPD could be more beneficial if they are used by people who were recently diagnosed with COPD, early in their care pathway. The companies should consider testing the technology at varied points in the NHS care pathway to determine the point where digital technologies could be most beneficial.

  • The digital technologies could be more beneficial if they are set up to ensure that language and cultural considerations of their users are met, and the digital literacy of people using the technologies are considered.

  • Evidence generation should be overseen by a steering group including researchers, commissioners, practitioners, and people with lived experience.

  • The evidence generation process is most likely to succeed with dedicated research staff to reduce the burden on NHS staff, and by using suitable real-world data to collect information when possible.

  • Careful planning of the approach to information governance is vital. The companies should ensure that appropriate structures and policies are in place to ensure that the data is handled in a confidential and secure manner, and to appropriate ethical and quality standards.

  • Recording multiple baseline measures is likely to be challenging. So, the issue of apparent improvement in outcome measurement being potentially caused by 'regression to the mean' effect could be best considered though statistical approaches in analysis, for example, through analysis of covariance (ANCOVA).

  • Using the EQ-5D requires a licence, with an associated cost.

ISBN: [to be added at publication]